These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3757883)

  • 1. [Immunochemical study of antigens in the ascitic fluid of patients with ovarian cancer].
    Sergeeva NS; Vasil'ev MIu; Avdeev GI
    Eksp Onkol; 1986; 8(4):37-40. PubMed ID: 3757883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical study of one of ascitic fluid antigens in patients with ovarian cancer using normal and tumor tissues].
    Sergeeva NS; Vasil'ev MIu; Sokolova NV; Avdeev GI
    Eksp Onkol; 1988; 10(1):20-2. PubMed ID: 3131099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution of one of the ascitic fluid antigens of ovarian cancer patients in malignant tumors of the stomach and intestines].
    Sergeeva NS; Vasil'ev MIu; Kovalenko TI; Sokolova NV; Avdeev GI
    Eksp Onkol; 1989; 11(2):35-7. PubMed ID: 2661204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
    Rao GS; Hanjani P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunochemical identification of onco-ovarian acid-soluble alpha-2-globulin].
    Prokopenko PG; Borisenko SA; Makarov OV; Tatarinov IuS
    Biull Eksp Biol Med; 1991 Aug; 112(8):185-8. PubMed ID: 1723903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunochemical identification of beta2-globulin in metastases of ovarian tumors].
    Prokopenko PG; Borisenko SA; Tatarinov IuS
    Biull Eksp Biol Med; 1988 Jul; 106(7):81-3. PubMed ID: 3042035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian carcinoma-associated antigen isolated from peritoneal effusions in clinical diagnosis].
    Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):242-6. PubMed ID: 6426896
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunochemical identification of a new embryonal antigen in ovarian tumor tissue].
    Kalashnikov VV; Borisenko SA; Tatarinov IS
    Biull Eksp Biol Med; 1976 Jun; 81(6):725-6. PubMed ID: 953311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comments on the paper by Schröck et al., The simultaneous determination of Ca 125 and D-dimer in plasma and ascitic fluid in ovarian cancer].
    Mezger J
    Onkologie; 1986 Feb; 9(1):10. PubMed ID: 3523340
    [No Abstract]   [Full Text] [Related]  

  • 10. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.
    Barker SD; Casado E; Gomez-Navarro J; Xiang J; Arafat W; Mahasreshti P; Pustilnik TB; Hemminki A; Siegal GP; Alvarez RD; Curiel DT
    Gynecol Oncol; 2001 Jul; 82(1):57-63. PubMed ID: 11426962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
    Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis of ovarian cancer.
    Popkin DR
    Can Med Assoc J; 1979 May; 120(9):1106-8. PubMed ID: 445304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Organ-specific intestinal antigens contained in tumors of the human gastrointestinal tract].
    Pugachev KK; Vasil'ev MIu; Avdeev GI
    Eksp Onkol; 1986; 8(2):45-8. PubMed ID: 3084194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer: immunologic diagnosis and therapy.
    Barber HR; Dorsett B
    Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
    [No Abstract]   [Full Text] [Related]  

  • 15. An ovarian cancer-associated antigen that crossreacts with a pregnancy-associated protein.
    Nakai M; Ohsawa Y; Nagata E; Arai M
    Eur J Obstet Gynecol Reprod Biol; 1987 Jan; 24(1):39-48. PubMed ID: 2434369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an ectopic developmental antigen that appears in malignant ascitic fluid.
    Nakai M; Ishikawa M; Kawauchi H
    Eur J Obstet Gynecol Reprod Biol; 1991 Nov; 42(1):61-9. PubMed ID: 1663874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
    Qian HN; Feng J; Fu TY
    Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K.
    Zeimet AG; Stadlmann S; Natoli C; Widschwendter M; Hermann M; Abendstein B; Daxenbichler G; Offner FA; Iacobelli S; Marth C
    Anticancer Res; 2000; 20(6B):4507-11. PubMed ID: 11205296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.